The significance of APP, PSEN1, and PSEN2 in AD were confirmed by different genetic studies, and majority of these mutations share a common feature of exhibiting increased production of the Aβ1-42 peptide, associated with altered gamma secretase activity [5,14]. The gene discussed is PSEN1; the disease is Alzheimer disease.